Phase II study of induction gemcitabine and S-1 followed by chemoradiotherapy and systemic chemotherapy using S-1 for locally advanced pancreatic cancer

被引：0
|
作者：
Kentaro Sudo
Ryusuke Hara
Kazuyoshi Nakamura
Emiri Kita
Akiko Tsujimoto
Taketo Yamaguchi
机构：
[1] Chiba Cancer Center,Department of Gastroenterology
[2] Chiba Cancer Center,Department of Radiation Oncology
来源：
Cancer Chemotherapy and Pharmacology | 2017年 / 80卷
关键词：
Pancreatic cancer; Gemcitabine; S-1; Chemoradiotherapy; Induction chemotherapy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：195 / 202
页数：7
相关论文
共 50 条
  • [31] Phase II trial of S-1 in combination with gemcitabine for chemo-naïve patients with locally advanced or metastatic pancreatic cancer
    Gyeong-Won Lee
    Hye Jung Kim
    Ji-Hyun Ju
    Seok-Hyun Kim
    Hoon Gu Kim
    Tae Hyo Kim
    Hyun Jin Kim
    Chi-Young Jeong
    Jung Hun Kang
    Cancer Chemotherapy and Pharmacology, 2009, 64
  • [32] Pilot study of neoadjuvant chemotherapy with gemcitabine and oral S-1 for resectable pancreatic cancer
    Tajima, Hidehiro
    Ohta, Tetsuo
    Kitagawa, Hirohisa
    Okamoto, Koichi
    Sakai, Seisho
    Makino, Isamu
    Kinoshita, Jun
    Furukawa, Hiroyuki
    Nakamura, Keishi
    Hayashi, Hironori
    Oyama, Katsunobu
    Inokuchi, Masafumi
    Nakagawara, Hisatoshi
    Fujita, Hideto
    Takamura, Hiroyuki
    Ninomiya, Itasu
    Fushida, Sachio
    Tani, Takashi
    Fujimura, Takashi
    Ikeda, Hiroko
    Kitamura, Seiko
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2012, 3 (05) : 787 - 792
  • [33] A phase I trial of S-1 with concurrent radiotherapy for locally advanced pancreatic cancer
    M Ikeda
    T Okusaka
    Y Ito
    H Ueno
    C Morizane
    J Furuse
    H Ishii
    M Kawashima
    Y Kagami
    H Ikeda
    British Journal of Cancer, 2007, 96 : 1650 - 1655
  • [34] A phase I study of neoadjuvant chemotherapy with gemcitabine plus oral S-1 for resectable pancreatic cancer
    Tajima, Hidehiro
    Kitagawa, Hirohisa
    Tsukada, Tomoya
    Nakanuma, Shinich
    Okamoto, Koichi
    Sakai, Seisho
    Makino, Isamu
    Furukawa, Hiroyuki
    Nakamura, Keishi
    Hayashi, Hironori
    Oyama, Katsunobu
    Inokuchi, Masafumi
    Nakagawara, Hisatoshi
    Miyashita, Tomoharu
    Fujita, Hideto
    Itoh, Hiroshi
    Takamura, Hiroyuki
    Ninomiya, Itasu
    Fushida, Sachio
    Fujimura, Takashi
    Ohta, Tetsuo
    MOLECULAR AND CLINICAL ONCOLOGY, 2013, 1 (04) : 768 - 772
  • [35] Phase II trial of S-1 and concurrent radiotherapy in patients with locally advanced pancreatic cancer
    Hee Man Kim
    Seungmin Bang
    Jeong Youp Park
    Jinsil Seong
    Si Young Song
    Jae Bock Chung
    Seung Woo Park
    Cancer Chemotherapy and Pharmacology, 2009, 63 : 535 - 541
  • [36] Multicenter, phase II study of gemcitabine and S-1 combination chemotherapy in patients with advanced biliary tract cancer
    Takashi Sasaki
    Hiroyuki Isayama
    Yousuke Nakai
    Yukiko Ito
    Hirofumi Kogure
    Osamu Togawa
    Nobuo Toda
    Ichiro Yasuda
    Osamu Hasebe
    Iruru Maetani
    Naoki Sasahira
    Kenji Hirano
    Takeshi Tsujino
    Minoru Tada
    Masao Omata
    Cancer Chemotherapy and Pharmacology, 2010, 65 : 1101 - 1107
  • [37] A phase II trial of gemcitabine, S-1 and LV combination (GSL) therapy in patients with advanced pancreatic cancer
    Saito, Kei
    Isayama, Hiroyuki
    Nakai, Yousuke
    Takahara, Naminatsu
    Ishigaki, Kazunaga
    Takeda, Tsuyoshi
    Hakuta, Ryunosuke
    Saito, Tomotaka
    Uchino, Rie
    Kishikawa, Takahiro
    Hamada, Tsuyoshi
    Mizuno, Suguru
    Sasaki, Takashi
    Kogure, Hirofumi
    Matsubara, Saburo
    Yamamoto, Natsuyo
    Ijichi, Hideaki
    Tateishi, Keisuke
    Tada, Minoru
    Koike, Kazuhiko
    INVESTIGATIONAL NEW DRUGS, 2019, 37 (02) : 338 - 344
  • [38] Gemcitabine plus S-1 for metastatic pancreatic cancer
    Zhu, Hong
    Yi, Cheng
    Zhao, Yaqin
    Gou, Hongfeng
    MEDICINE, 2018, 97 (41)
  • [39] Multicenter, phase II study of gemcitabine and S-1 combination chemotherapy in patients with advanced biliary tract cancer
    Sasaki, Takashi
    Isayama, Hiroyuki
    Nakai, Yousuke
    Ito, Yukiko
    Kogure, Hirofumi
    Togawa, Osamu
    Toda, Nobuo
    Yasuda, Ichiro
    Hasebe, Osamu
    Maetani, Iruru
    Sasahira, Naoki
    Hirano, Kenji
    Tsujino, Takeshi
    Tada, Minoru
    Omata, Masao
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2010, 65 (06) : 1101 - 1107
  • [40] A phase II trial of gemcitabine, S-1 and LV combination (GSL) therapy in patients with advanced pancreatic cancer
    Kei Saito
    Hiroyuki Isayama
    Yousuke Nakai
    Naminatsu Takahara
    Kazunaga Ishigaki
    Tsuyoshi Takeda
    Ryunosuke Hakuta
    Tomotaka Saito
    Rie Uchino
    Takahiro Kishikawa
    Tsuyoshi Hamada
    Suguru Mizuno
    Takashi Sasaki
    Hirofumi Kogure
    Saburo Matsubara
    Natsuyo Yamamoto
    Hideaki Ijichi
    Keisuke Tateishi
    Minoru Tada
    Kazuhiko Koike
    Investigational New Drugs, 2019, 37 : 338 - 344
12345